PharVision Advisers’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
VPM
VCM
HRCM
PharVision Advisers's ALHC Position: Q1 2026 in Review
PharVision Advisers sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 18,122 shares — an estimated $358K sold.
PharVision Advisers first reported a position in ALHC in Q4 2025 and held it in 1 quarter. The position peaked at $358K in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.
- PharVision Advisers reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
- PharVision Advisers sold 18,122 Alignment Healthcare shares in Q1 2026, an estimated $358K.
- PharVision Advisers first reported a position in Alignment Healthcare in Q4 2025 and held it in 1 quarter.
- PharVision Advisers's Alignment Healthcare position peaked at $358K in Q4 2025.
- 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.